Condition: Acute Biphenotypic Leukemia · Acute Leukemia · Acute Leukemia of Ambiguous Lineage · Sponsor: Fred Hutchinson Cancer Center
This phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor stem cell transplant. Sometimes the transplanted white blood cells from a donor attack the body's normal tissues (called graft versus host disease). Removing a particular type of T cell (naive T cells) from the donor cells before the transplant may stop this from happening.
This description comes directly from the study's public registry record.
Marie Bleakley · 206-667-6572 · mbleakle@fredhutch.org
Always discuss trial participation with your own doctor first.
| Children's Hospital of Los Angeles | Los Angeles, California, United States | Recruiting |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | Withdrawn |
| Children's Healthcare of Atlanta | Atlanta, Georgia, United States | Not Yet Recruiting |
| University of Iowa/Holden Comprehensive Cancer Center | Iowa City, Iowa, United States | Recruiting |
| Dana Farber / Boston Children's Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| UH Rainbow Babies and Children's Hospital (University Hospitals Cleveland Medical Center) | Cleveland, Ohio, United States | Not Yet Recruiting |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | Recruiting |
| Oregon Health and Science University | Portland, Oregon, United States | Recruiting |
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh, Pennsylvania, United States | Recruiting |
| Fred Hutch/University of Washington Cancer Consortium | Seattle, Washington, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03779854